What gene is most strongly associated with male breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Male Breast Cancer is Most Strongly Associated with BRCA2 Gene

Male breast cancer is most strongly associated with the BRCA2 gene, with a lifetime risk of up to 8% in carriers, compared to only 1.2% for BRCA1 carriers. 1

Genetic Associations with Male Breast Cancer

BRCA2 - Primary Association

  • BRCA2 mutations confer the highest risk for male breast cancer:
    • Lifetime risk of 6-8% by age 70 years 1, 2
    • This is substantially higher than the general population risk of ~0.1% 1
    • BRCA2 is the main male breast cancer susceptibility gene, accounting for approximately 10% of all male breast cancer cases 1, 3

BRCA1 - Secondary Association

  • BRCA1 mutations are associated with male breast cancer but at significantly lower rates:
    • Lifetime risk of only 1.2% by age 70 years 1, 2
    • Only 0-4% of male breast cancer cases have BRCA1 mutations 1

Other Genetic Associations

  • Other genes associated with male breast cancer include:
    • PALB2 - emerging evidence suggests increased risk 1, 4, 3
    • CHEK2 - confers moderate risk 1, 3
    • PTEN - less common but appears to confer elevated risk 1

Risk Modifiers in Male Breast Cancer

  • Risk can be substantially increased in BRCA2 carriers with:
    • Gynaecomastia (RR 9.8) 1
    • Klinefelter syndrome (RR 24.7) 1
    • Family history of breast cancer 1, 5

Clinical Implications

  • All male breast cancer patients should be offered genetic counseling and testing for germline mutations 1
  • Annual mammography or ultrasound screening should be considered in male BRCA2 carriers with additional high-risk features from age 50 or 10 years before the earliest male breast cancer in the family 1
  • Male BRCA2 carriers should be encouraged to be aware of physical changes in the breast and seek medical attention accordingly 1

Pathological Features

  • BRCA2-associated male breast cancers tend to be of higher grade than sporadic male breast cancers 6
  • BRCA2 male breast cancers are more likely to be estrogen receptor-positive and progesterone receptor-positive compared to BRCA2 female breast cancers 6

In conclusion, while multiple genes can contribute to male breast cancer risk, the BRCA2 gene shows the strongest and most consistent association, with substantially higher risk than BRCA1 or other breast cancer susceptibility genes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cancer Genetics and Risk Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.